Disc Medicine, Inc.
IRON
$59.14
-$0.85-1.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -212.18M | -181.11M | -145.39M | -116.49M | -109.36M |
| Total Depreciation and Amortization | 281.00K | 201.00K | 125.00K | 150.00K | 156.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.98M | 21.61M | 15.33M | 12.01M | 12.04M |
| Change in Net Operating Assets | 3.53M | -5.37M | -4.29M | 2.63M | 3.23M |
| Cash from Operations | -180.39M | -164.67M | -134.23M | -101.70M | -93.93M |
| Capital Expenditure | -933.00K | -1.36M | -1.33M | -1.29M | -505.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -393.37M | -171.47M | -292.13M | -563.61M | -291.83M |
| Cash from Investing | -394.30M | -172.83M | -293.46M | -564.90M | -292.33M |
| Total Debt Issued | -- | 28.99M | 28.99M | 28.99M | 28.99M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 459.33M | 248.55M | 237.39M | 409.68M | 190.72M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 14.08M | 7.99M | 7.99M | 7.99M | -1.39M |
| Cash from Financing | 473.41M | 285.53M | 274.37M | 446.67M | 218.31M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -101.29M | -51.97M | -153.32M | -219.94M | -167.94M |